Panacea Life Sciences Holdings Inc (PLSH)

[DrKrassenDimitrov]

Regarding FDA/Congress: yes, that's more or less my take as well. It's about mainstream-ization.

It's not as much as that the "FDA got in the way", it's more that the big chains want affirmative action from FDA/Congress before committing seriously. In the Brightfield projections the mainstream chains get-in a bit later, but they account for a large chunk ($13B) of the $22B projected for 2022. Now this seems pushed back a bit further out.

So, now the situation seems to be that the online/dispensary/enthusiast/early-adopter market is oversupplied and the mainstream market is still not taking off, and growth has stalled as a result. And the idea is that some affirmative action from FDA would help. (there are no barriers or restrictions, just lack of explicit affirmations).

That's not uncommon for emerging industries: adoption is not always smooth and straight, there are hitches and bumps sometimes. It is in times like these that the scams and the "pump-and-dump" schemes leave the scene, while the strong players survive and emerge even stronger, with larger market shares.

The question is, what is EXDI? We hope it is a solid company that will emerge stronger, but I personally have some serious concerns...